Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Intraperitoneal Carboplatin in Recurrent Ovarian Cancer
NCT00562185Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2008
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, carboplatin in ovarian cancer, sponsored by UT Southwestern Medical Center. Planned start May 2008; status: withdrawn.
02
Drugs
doxorubicincarboplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00562185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562185.